O2‐13‐04: Early Clinical Results and Preclinical Validation of the O‐Glcnacase (OGA) Inhibitor Mk‐8719 as a Novel Therapeutic for the Treatment of Tauopathies. (1st July 2016) - Smith, Sean M.; Struyk, Arie; Jonathan, Daniel; Declercq, Ruben; Marcus, Jacob; Toolan, Dawn; Wang, Xiaohai; Schachter, Joel B.; Cosden, Mali; Pearson, Michelle; Hess, Fred; Selnick, Harold; et al.